Citi Sees Limited Sales For Blood-Clot Drug At The Medicines Company

By: via Benzinga
The Medicines Company (NASDAQ: MDCO)'s blood-clot prevention drug will serve as a last-line treatment with limited sales, an analyst ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.